Pharmafile - Sales and Marketing News
According to an academic paper on the efficacy of CanSinoBIO’s recombinant COVID-19 vaccine, published on medRxiv, the vaccine is effective as a...
A surge in COVID-19 cases was to be “expected”, following the ease of pandemic restrictions in England, insisted UK Health Secretary Sajid Javid.
LYNPARZA® (olaparib) has been approved in the US for the adjuvant treatment of patients with germline BRCA-mutated (gBRCAm) HER2-negative high-risk...
Khairy Jamaluddin, Health Minister of Malaysia, has shared that the country expects to receive its first shipment of Pfizer’s oral antiviral COVID-19...
HUTCHMED has received $15 million from AstraZeneca, for the initiation of start-up activities for SAFFRON, the first global Phase III study for...
Syndesi Therapeutics has been acquired by AbbVie in a deal worth a potential $1 billion.
Zydus Lifesciences received approval from the Drugs Controller General of India (DCGI) for its new drug application for Oxemia (Desidustat). Oxemia...
Actigen has initiated a clinical development programme for GNR-055, a potentially breakthrough treatment for the debilitating, life-limiting, rare...
Results from a Phase III trial have revealed that adding Dupixent (dupilumab) to standard-of-care antihistamines significanty reduced itch and hives...
Kidney Research UK has released their findings from a survey of 1,000 kidney disease patients in the UK, revealing the significant impact the disease...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
